Drugs / SIBP-A16
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07363837 | Jan 2026 → Mar 2027 expected | respiratory syncytial virus infectious disease | Shanghai Institute Of Biological Products | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SIBP-A16 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07363837 ↗ |
| Route | Intramuscular | “via intramuscular or intravenous injection” NCT07363837 ↗ |
| Route | Intravenous | “via intramuscular or intravenous injection” NCT07363837 ↗ |